WuXi Biologics
Offering End-to-End Solutions
Other Molecular Modalities
WuXi Biologics offers extensive design, generation, and discovery of new molecular modalities, including but not limited to: bispecific/multispecific antibodies, ADC, recombinant proteins, fusion proteins, cytokines, immunocytokine, peptides, nanobodies, antibody fragments, TCR-based antibodies, varus proteins, and other biologics. Our team of experts work with you to establish the best path in optimizing your molecule to its target and for its intended purpose.
ADC
WuXi Biologics greatly simplifies ADC and other bioconjugate drug development by providing all stages of preclinical discovery, holistic and integrated CMC development process, and the entire supply chain for ADC projects under one company and in one centralized region. Our services include extensive R&D capabilities and world-class expertise to generate, engineer, evaluate and optimize antibody drug conjugate (ADC) / bioconjugate lead candidates. Of note are services specifically for ADC in vitro characterization:
Learn more about our capabilities for ADC’s:
Fusion Protein
Our Fusion Protein Services include the following. For additional services please Contact Us.
Cytokine/Immunocytokine
Cytokine/Immunocytokine services are available. For additional services please Contact Us.
Other Protein Design and Engineering Services Available. For additional services please Contact Us.
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?